Literature DB >> 24731281

Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents.

Ji-Wen Yuan1, She-Feng Wang1, Zhong-Liang Luo1, Han-Yue Qiu1, Peng-Fei Wang1, Xin Zhang1, Yong-An Yang1, Yong Yin1, Fei Zhang1, Hai-Liang Zhu2.   

Abstract

A series of compounds which contain pyrazole, thiazole and naphthalene ring (1a-7a, 1b-7b, 1c-7c, 1d-7d) were firstly synthesized and their anti-proliferative activity, EGFR inhibitory activity, cytotoxicity and inhibition to Hela cell migration were evaluated. Compound 2-(3-(3,4-dimethylphenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (7d) displayed the most potent inhibitory activity (IC50=0.86μM for Hela and IC50=0.12μM for EGFR). Structure-activity relationship (SAR) analysis showed that the anti-proliferative activity was affected by A-ring-substituent (-OCH3>-CH3>-H>-Br>-Cl>-F). Docking simulation of compound 7d into EGFR active site showed that naphthalene ring of 7d with LYS721 formed two p-π bonds, which enhanced antitumor activity. Therefore, compound 7d may be developed as a potential antitumor agent.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-tumor activity; Cell migration; EGFR inhibitors; Structure–activity relationship

Mesh:

Substances:

Year:  2014        PMID: 24731281     DOI: 10.1016/j.bmcl.2014.03.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.

Authors:  Tarfah Al-Warhi; Ahmed M El Kerdawy; Mohamed A Said; Amgad Albohy; Zainab M Elsayed; Nada Aljaeed; Eslam B Elkaeed; Wagdy M Eldehna; Hatem A Abdel-Aziz; Miral A Abdelmoaz
Journal:  Drug Des Devel Ther       Date:  2022-05-16       Impact factor: 4.319

2.  2-Phenylnaphthalene Derivatives Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Mediators by Downregulating of MAPK/NF-κB Pathways in RAW 264.7 Macrophage Cells.

Authors:  Chi-Fen Chang; Kang-Chun Liao; Chung-Hwan Chen
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

3.  Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives.

Authors:  Moustafa T Gabr; Nadia S El-Gohary; Eman R El-Bendary; Mohamed M El-Kerdawy; Nanting Ni
Journal:  EXCLI J       Date:  2017-08-30       Impact factor: 4.068

4.  Modular synthesis of thiazoline and thiazole derivatives by using a cascade protocol.

Authors:  Zakeyah A Alsharif; Mohammad A Alam
Journal:  RSC Adv       Date:  2017-06-26       Impact factor: 3.361

5.  Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer.

Authors:  Anusha Sebastian; Vijay Pandey; Chakrabhavi Dhananjaya Mohan; Yi Ting Chia; Shobith Rangappa; Jessin Mathai; C P Baburajeev; Shardul Paricharak; Lewis H Mervin; Krishna C Bulusu; Julian E Fuchs; Andreas Bender; Shuhei Yamada; Peter E Lobie; Kanchugarakoppal S Rangappa
Journal:  ACS Omega       Date:  2016-12-28

6.  Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer.

Authors:  Esraa A Abdelsalam; Amer Ali Abd El-Hafeez; Wagdy M Eldehna; Mahmoud A El Hassab; Hala Mohamed M Marzouk; Mahmoud M Elaasser; Nageh A Abou Taleb; Kamilia M Amin; Hatem A Abdel-Aziz; Pradipta Ghosh; Sherif F Hammad
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

7.  Structure-Activity Relationship of Synthetic 2-Phenylnaphthalenes with Hydroxyl Groups that Inhibit Proliferation and Induce Apoptosis of MCF-7 Cancer Cells.

Authors:  Chi-Fen Chang; Ci-Yi Ke; Yang-Chang Wu; Ta-Hsien Chuang
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.